Verona Pharma plc financial data

Symbol
VRNA on Nasdaq
Industry
Pharmaceutical Preparations
Location
3 More London Riverside, London, United Kingdom
State of incorporation
United Kingdom
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.13K % -46.5%
Debt-to-equity 117 % +653%
Return On Equity -95.2 % -365%
Return On Assets -43.9 % -148%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 680M shares +4.81%
Common Stock, Shares, Outstanding 655M shares +2.37%
Entity Public Float 1.1B USD -26.7%
Common Stock, Value, Issued 45M USD +5.26%
Weighted Average Number of Shares Outstanding, Basic 652M shares +2.87%
Weighted Average Number of Shares Outstanding, Diluted 652M shares +2.87%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 5.62M USD
Research and Development Expense 44.3M USD -47%
General and Administrative Expense 150M USD +197%
Operating Income (Loss) -155M USD -129%
Nonoperating Income (Expense) -8.5M USD -162%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -163M USD -203%
Income Tax Expense (Benefit) 10.3M USD +2071%
Net Income (Loss) Attributable to Parent -173M USD -219%
Earnings Per Share, Basic -0.27 USD/shares -200%
Earnings Per Share, Diluted -0.27 USD/shares -200%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 400M USD +47.1%
Accounts Receivable, after Allowance for Credit Loss, Current 31.5M USD
Inventory, Net 6.25M USD
Other Assets, Current 2.74M USD -18.7%
Assets, Current 454M USD +56.6%
Property, Plant and Equipment, Net 1.11M USD +4504%
Operating Lease, Right-of-Use Asset 2.05M USD -28.1%
Goodwill 545K USD 0%
Assets 474M USD +53.9%
Accounts Payable, Current 11.3M USD +223%
Employee-related Liabilities, Current 2.93M USD +269%
Accrued Liabilities, Current 16.8M USD +367%
Contract with Customer, Liability, Current 687K USD
Liabilities, Current 42.7M USD +391%
Contract with Customer, Liability, Noncurrent 105M USD
Operating Lease, Liability, Noncurrent 1.24M USD -30.1%
Liabilities 270M USD +358%
Accumulated Other Comprehensive Income (Loss), Net of Tax -4.6M USD 0%
Retained Earnings (Accumulated Deficit) -562M USD -44.8%
Stockholders' Equity Attributable to Parent 205M USD -17.9%
Liabilities and Equity 474M USD +53.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -13.6M USD -135%
Net Cash Provided by (Used in) Financing Activities -3.12M USD -105%
Net Cash Provided by (Used in) Investing Activities -16K USD
Common Stock, Shares, Issued 703M shares +5.32%
Common Stock, Par or Stated Value Per Share 0.05 GBP/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -16.9M USD -127%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 400M USD +47.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 933K USD +282%
Deferred Tax Assets, Valuation Allowance 98.5M USD +77.4%
Deferred Tax Assets, Gross 181M USD +65.2%
Operating Lease, Liability 2.36M USD -20.1%
Payments to Acquire Property, Plant, and Equipment 16K USD
Lessee, Operating Lease, Liability, to be Paid 2.74M USD -23.8%
Operating Lease, Liability, Current 1.12M USD -5.09%
Lessee, Operating Lease, Liability, to be Paid, Year Two 841K USD -0.12%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.11M USD -5.28%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 375K USD -40.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 782K USD -0.76%
Deferred Tax Assets, Operating Loss Carryforwards 65.3M USD +20.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 784K USD
Additional Paid in Capital 728M USD +21.2%
Depreciation, Depletion and Amortization 263K USD +67.5%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 41.2M USD +117%
Interest Expense 13.8M USD +732%